European Hospital Directory 2022: List of the Largest 6000 Hospitals Ranked by Revenue in $USm – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Database of Hospitals in Europe” database has been added to ResearchAndMarkets.com’s offering. The Database of Hospitals in Europe is an Excel spreadsheet containing a list of the largest 6000 Hospitals in Europe. Each of our company lists displays the leading companies ranked by revenue in $USm. Each Excel file contains the following: Company … [Read more…]

Checkpoint Inhibitors Global Market Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Checkpoint Inhibitors Global Market Report 2022: By Drug, By Application, By End-Users” report has been added to ResearchAndMarkets.com’s offering. Checkpoint Inhibitors Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global checkpoint inhibitors market. This report focuses on checkpoint inhibitors market which … [Read more…]

Apple Brompton Road Celebrates Creativity With Vibrant Design and Events Featuring Local Artists

The new London store offers advancements in sustainable design, community events and resources, and a team of more than 200 ready to provide excellent service for customers LONDON–(BUSINESS WIRE)–Apple® today previewed Apple Brompton Road, its newest store in London, located in the city’s bustling Knightsbridge neighborhood. A stone’s throw from Hyde Park, Apple Brompton Road … [Read more…]

Global Drug Taste Masking and Taste Assessment Services and Technologies Market Report 2022-2035 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Taste Masking and Taste Assessment Services and Technologies Market, Distribution by Type of Formulation, Type of Techniques, Scale of Operation and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. ‘Taste Masking and Taste Assessment Services and Technologies Market, 2022-2035 report features an extensive study of … [Read more…]

Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and the SEA countries

SINGAPORE–(BUSINESS WIRE)–#HD204—Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas Pharmaceuticals Limited (hereafter referred to as “Intas”) today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige Biopharma’s bevacizumab biosimilar, in the US, Europe, Canada, MENA, Brazil, Mexico, South … [Read more…]

Acquired von Willebrand Disease (AvWD) Treatment Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Acquired von Willebrand Disease (AvWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The acquired von willebrand disease treatment market is anticipated to grow, at a CAGR of 5.86% during the forecast period of … [Read more…]

Seagen and Astellas Announce Positive Topline Results For PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) as First-Line Treatment for Advanced Urothelial Cancer

– Companies plan to discuss results with regulatory authorities – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced positive topline results from the phase 1b/2 EV-103 clinical trial (also known as KEYNOTE-869) Cohort K evaluating PADCEV® (enfortumab vedotin-ejfv) in combination with Merck’s … [Read more…]

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension

PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings Co., Ltd., today announced that the RADIANCE II US FDA IDE pivotal trial evaluating the Paradise™ Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant … [Read more…]

SMOORE Opens First PMTA Testing Laboratory in China

SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China’s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA). A PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the … [Read more…]

Insempra Announces Strategic Investment in Solena Materials

Strategic investment to support the foundation of Solena Materials, a spin-out from Imperial College London, accelerating the development of synthetic fibers for high-performance, intrinsically sustainable clothing MUNICH–(BUSINESS WIRE)–Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today announces a strategic investment in Solena Materials Ltd (‘Solena’), a synthetic biology company. … [Read more…]